☆ 4.7 Article

Urolithin A protects dopaminergic neurons in experimental models of Parkinson's disease by promoting mitochondrial biogenesis through the SIRT1/PGC-1α signaling pathway

FOOD & FUNCTION (2022)

Related references

Note: Only part of the references are listed.

Article Nutrition & Dietetics

Direct supplementation with Urolithin A overcomes limitations of dietary exposure and gut microbiome variability in healthy adults to achieve consistent levels across the population

Anurag Singh et al.

Summary: This study investigates the prevalence of UA producers in a healthy population and the effectiveness of direct UA supplementation in overcoming microbiome variability. Results show that 40% of subjects converted precursor compounds into UA after consuming pomegranate juice. UA producers were characterized by higher gut microbiome diversity and a specific bacteria ratio. Direct supplementation significantly increased plasma UA levels, providing a >6-fold exposure compared to PJ.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2022)

Add to Collection

Article Immunology

Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease

Yue Qin et al.

Summary: The study found that impaired microglial autophagy exacerbates neuroinflammation and dopaminergic neurodegeneration by modulating NLRP3 inflammasome responses. Enhancing microglial autophagy may be a promising new therapeutic strategy for PD.

BRAIN BEHAVIOR AND IMMUNITY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Mitochondrial Dysfunction and Mitophagy in Parkinson's Disease: From Mechanism to Therapy

Ana Belen Malpartida et al.

Summary: Mitochondrial dysfunction has long been associated with Parkinson's disease, although its exact role remains unclear. Recent discoveries on the role of PD familial genes in mediating mitophagy and the overlap with sporadic PD have opened up new opportunities for therapeutically targeting mitochondria in PD. Progress has also been made in understanding the upstream and downstream regulators of canonical and noncanonical PINK1/parkin-mediated mitophagy in response to mitochondrial damage.

TRENDS IN BIOCHEMICAL SCIENCES (2021)

Add to Collection

Review Cell Biology

Targeting Mitochondrial Impairment in Parkinson's Disease: Challenges and Opportunities

Jannik Prasuhn et al.

Summary: Parkinson's disease is complicated and mitochondrial dysfunction plays a key role in its pathophysiology. While there are still gaps in knowledge, targeting various aspects of mitochondrial function and using combined therapeutic approaches may offer the best chance for developing effective novel therapies.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Urolithin A ameliorates experimental autoimmune encephalomyelitis by targeting aryl hydrocarbon receptor

Pei-Xin Shen et al.

Summary: This study demonstrates the therapeutic effect of Urolithin A in an experimental autoimmune encephalomyelitis (EAE) animal model, with potential as a prospective therapeutic candidate for autoimmune diseases. The mechanism involves targeting the Aryl Hydrocarbon Receptor (AhR) and modulating signaling pathways to suppress inflammation and regulate immune cell functions at different stages of disease progression.

EBIOMEDICINE (2021)

Add to Collection

Review Pharmacology & Pharmacy

Natural products targeting mitochondria: emerging therapeutics for age-associated neurological disorders

Zhibin Liang et al.

Summary: Mitochondria, as the primary source of energy production in the brain, become inefficient and dysfunctional with age and in neurological disorders. Natural products are utilized as potential neuroprotective agents to restore mitochondrial function, highlighting both the value and challenges in the discovery and development of future neurotherapeutics.

PHARMACOLOGY & THERAPEUTICS (2021)

Add to Collection

Article Cell Biology

Urolithin A improves muscle function by inducing mitophagy in muscular dystrophy

Peiling Luan et al.

Summary: Research shows that decreased mitochondrial autophagy may contribute to mitochondrial dysfunction in Duchenne muscular dystrophy (DMD) patients and experimental models. However, administration of the mitophagy activator urolithin A can improve mitochondrial function and alleviate symptoms of DMD, suggesting potential therapeutic applications for muscular dystrophies.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Add to Collection

Article Biochemistry & Molecular Biology

Neuroprotective Effects of Pomegranate Juice against Parkinson's Disease and Presence of Ellagitannins-Derived Metabolite-Urolithin A-In the Brain

Malgorzata Kujawska et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Cell Biology

Mitochondrial biogenesis: An update

Lucia-Doina Popov

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Add to Collection

Article Geriatrics & Gerontology

Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson's Disease

Shaoqi Yan et al.

FRONTIERS IN AGING NEUROSCIENCE (2020)

Add to Collection

Article Cell & Tissue Engineering

Defects in Mitochondrial Biogenesis Drive Mitochondrial Alterations in PARKIN-Deficient Human Dopamine Neurons

Manoj Kumar et al.

STEM CELL REPORTS (2020)

Add to Collection

Article Neurosciences

Urolithin A Prevents Focal Cerebral Ischemic Injury via Attenuating Apoptosis and Neuroinflammation in Mice

Xiao-Hong Lin et al.

NEUROSCIENCE (2020)

Add to Collection

Article Immunology

Urolithin A attenuates memory impairment and neuroinflammation in APP/PS1 mice

Zhuo Gong et al.

JOURNAL OF NEUROINFLAMMATION (2019)

Add to Collection

Article Neurosciences

Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer's disease

Evandro F. Fang et al.

NATURE NEUROSCIENCE (2019)

Add to Collection

Article Neurosciences

Urolithin A-activated autophagy but not mitophagy protects against ischemic neuronal injury by inhibiting ER stress in vitro and in vivo

Anil Ahsan et al.

CNS NEUROSCIENCE & THERAPEUTICS (2019)

Add to Collection

Article Endocrinology & Metabolism

The mitophagy activator urolithin A is safe and induces a molecular signature of improved mitochondrial and cellular health in humans

Penelope A. Andreux et al.

NATURE METABOLISM (2019)

Add to Collection

Review Neurosciences

Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment

Mojtaba Golpich et al.

CNS NEUROSCIENCE & THERAPEUTICS (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Urolithin A induces mitophagy and prolongs lifespan in C-elegans and increases muscle function in rodents

Dongryeol Ryu et al.

NATURE MEDICINE (2016)

Add to Collection

Article Multidisciplinary Sciences

Promotion of mitochondrial biogenesis by necdin protects neurons against mitochondrial insults

Koichi Hasegawa et al.

NATURE COMMUNICATIONS (2016)

Add to Collection

Article Neurosciences

Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons

Haisong Jiang et al.

ENEURO (2016)

Add to Collection

Article Pharmacology & Pharmacy

Mitochondrial Biogenesis: A Therapeutic Target for Neurodevelopmental Disorders and Neurodegenerative Diseases

Martine Uittenbogaard et al.

CURRENT PHARMACEUTICAL DESIGN (2014)

Add to Collection

Review Integrative & Complementary Medicine

Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far

Juan Carlos Espin et al.

EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2013)

Add to Collection

Article Chemistry, Medicinal

In vivo anti-inflammatory and antioxidant properties of ellagitannin metabolite urolithin A

Hidekazu Ishimoto et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.